Comparison of oxidative stress and the frequency of polymorphisms in the HFE gene between hemoglobin S trait blood donors and sickle cell disease patients

Genetics and Molecular Research

Volumn 10, Issue 4, 2011, Pages 3446-3454

  Viana Baracioli, L M S ^a,b   Junior, N C Tukamoto ^a   Junior, O Ricci ^b   Mattos, L C ^c   Angulo I L ^d   Bonini Domingos, C R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Hemocentro   (Brazil)

^c Universidate Estadual Paulista   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidant capacity; Hemochromatosis; Hemoglobin S; Hemoglobinopathy; HFE

Indexed keywords

HEMOGLOBIN A; HEMOGLOBIN S; HFE PROTEIN; MALONALDEHYDE; 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID; ANTIOXIDANT; CHROMAN DERIVATIVE; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; TROLOX C;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRAIT; HFE GENE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; AGED; ANALYSIS OF VARIANCE; BLOOD; CHILD; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; SEXUAL DEVELOPMENT; SICKLE CELL TRAIT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BLOOD DONORS; CHILD; CHROMANS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN, SICKLE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MALONDIALDEHYDE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; SICKLE CELL TRAIT; YOUNG ADULT;

EID: 84865621772     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2011.December.8.4     Document Type: Article

References (25)

1. Agostinho MF, Arruda VR, Basseres DS, Bordin S, et al. (1999). Mutation analysis of the HFE gene in Brazilian populations. Blood Cells Mol. Dis. 25: 324-327.
2. Bandeira FMGC, Bezerra MAC, Santos MNN and Gomes YM (2007). Importância dos programas de triagem para o gene da hemoglobina S. Rev. Bras. Hematol. Hemoter. 29: 179-184.
3. Beutler E (2004). Iron absorption in carriers of the C282Y hemochromatosis mutation. Am. J. Clin. Nutr. 80: 799-800.
4. Beutler E, Lichtman MA, Coller BS and Kipps TJ (1995). Williams Hematology. 5th edn. International Edition, New York.
5. Bittencourt PL, Palacios SA, Couto CA, Cancado EL, et al. (2002). Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis. Braz. J. Med. Biol. Res. 35: 329-335.
6. Bonini-Domingos CR (2007). Aumento de ferro, hemocromatose hereditária e defeitos no gene HFE. O que conhecemos na população brasileira? Rev. Bras. Hematol. Hemoter. 29: 341-342.
7. Bonini-Domingos CR, Ondei LS and Zamaro PJA (2006). Hemoglobinas Similares a S no Brasil-Um Guia Prático de Identificação. 1ª ed. Editora HN, São José do Rio Preto.
8. Clegg JB and Weatherall DJ (1999). Thalassemia and malaria: new insights into an old problem. Proc. Assoc. Am. Physicians 111: 278-282.
9. Cullen LM, Gao X, Easteal S and Jazwinska EC (1998). The hemochromatosis 845 G→A and 187 C→G mutations: prevalence in non-Caucasian populations. Am. J. Hum. Genet. 62: 1403-1407.
10. de Souza AF, Carvalho-Filho RJ and Chebli JF (2001). Hereditary hemochromatosis. Case report and review of the literature. Arq. Gastroenterol. 38: 194-202.
11. Ferreira ACS, Oliveira VC, Caxito FA and Gomes KB (2008). Prevalence of C282Y and H63D mutations in the gene of Brazilian individuals with clinical suspicion of hereditary hemochromatosis. Rev. Bras. Hematol. Hemoter. 30: 379-383.
12. Fleming RE and Britton RS (2006). Iron Imports. VI. HFE and regulation of intestinal iron absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G590-G594.
13. Frenette PS and Atweh GF (2007). Sickle cell disease: old discoveries, new concepts, and future promise. J. Clin. Invest. 117: 850-858.
14. Higgs DR and Weatherall DJ (1993). Thalassaemia. In: The Haemoglobinopathies (WB Saunders, ed.). Baillière's Clinical Hematology, London, 117.
15. Jeng MR, Adams-Graves P, Howard TA, Whorton MR, et al. (2003). Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease. Am. J. Hematol. 74: 243-248.
16. Naoum PC and Souza PC (2004). Avaliação dos produtos da degradação oxidativa da Hb S nos genótipos SS, SF (S/beta 0 talassemia) e AS, em comparação com hemoglobinas normais. Rev. Bras. Patol. Med. Lab. 40: 249-259.
17. Parra FC, Amado RC and Lambertucci JR (2003). Color and genomic ancestry in Brazilians. PNAS 100: 177-182.
18. Percário S (1999). Dosagem do Dialdeido Malônico. NEWSLAB, 46-50.
19. Pietrangelo A (2006). Hereditary hemochromatosis. Biochim. Biophys. Acta 1763: 700-710.
20. Powell LW (2002). Diagnosis of hemochromatosis. Semin. Gastrointest. Dis. 13: 80-88.
21. Re R, Pellegrini N, Proteggente A, Pannala A, et al. (1999). Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26: 1231-1237.
22. Serjeant GR (1992). Sickle Cell Disease. 2nd edn. Oxford University Press Inc., New York.
23. Siah CW, Ombiga J, Adams LA, Trinder D, et al. (2006). Normal iron metabolism and the pathophysiology of iron overload disorders. Clin. Biochem. Rev. 27: 5-16.
24. Torres FR, Souza-Neiras WC, D'Almeida Couto AA, D'Almeida Couto VS, et al. (2008). Frequency of the HFE C282Y and H63D polymorphisms in Brazilian malaria patients and blood donors from the Amazon region. Genet. Mol. Res. 7: 60-64.
25. Weatherall DJ and Clegg JB (2001). Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 79: 704-712.